ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Could treating psoriasis in the future be as easy as going online?
worldpharmanews
October 09, 2018For approximately 8 million Americans, visiting a doctor regularly is the key to managing their psoriasis, a chronic inflammatory skin condition characterized by itchy or painful red patches that can appear anywhere on the body. -
Novartis bags rights to Galapagos/MorphoSys atopic dermatitis drug
pharmatimes
July 20, 2018Novartis has signed an exclusive global license agreement with Galapagos and MorphoSys for MOR106, a novel antibody directed against IL-17C. -
Atopic dermatitis patients to be denied NHS access to Dupixent
pharmatimes
July 19, 2018The National Institute for Health and Care Excellence has issued draft guidance rejecting Sanofi/Regeneron’s Dupixent (dupilumab) for the treatment of moderate-to-severe atopic dermatitis. -
Lilly/Incyte's baricitinib musters mixed data in atopic dermatitis trial
fiercebiotech
September 18, 2017In a phase 2 atopic dermatitis trial, Eli Lilly and Incyte's baricitinib hit its primary endpoint but missed a secondary objective, prompting unfavorable comparisons with Sanofi and Regeneron's recently approved Dupixent.
Pharma Sources Insight July 2025
